On August 24, 2026, UBS Group AG sold 2.63 million shares of LUYE PHARMA at an average of HKD 2.1485 per share, involving about HKD 5.64 million.
Prior to the disposal, UBS Group AG's long position in LUYE PHARMA was 521.25 million shares, representing 13.05%; following the disposal, the holding changed to 518.62 million shares, with the long position ratio falling to 12.98%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.